Predicting later-life outcomes of early-life exposures

Environmental Health Perspectives

Volumn 120, Issue 10, 2012, Pages 1353-1361

  Boekelheide, Kim ^a   Blumberg, Bruce ^b   Chapin, Robert E ^c   Cote, Ila ^d   Graziano, Joseph H ^e   Janesick, Amanda ^b   Lane, Robert ^f   Lillycrop, Karen ^g   Myatt, Leslie ^h   States, J Christopher ⁱ   Thayer, Kristina A ^j   Waalkes, Michael P ^j   Rogers, John M ^k  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^d U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^e Mailman School of Public Health   (United States)

^f UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^h University of Texas Health Science Center at San Antonio   (United States)

ⁱ University of Louisville School of Medicine   (United States)

^j NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^k U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

more..

Author keywords

Arsenic; Development; Epigenetics; Exposure; Fetal; Malnutrition; Obesogen; PPAR

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 2; ACYL COENZYME A OXIDASE; ARSENIC; CARCINOGEN; MESSENGER RNA; MICRORNA 126; MICRORNA 16; MICRORNA 21; ORGANOTIN COMPOUND; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); RETINOID X RECEPTOR ALPHA;

ADIPOCYTE; CARCINOGENESIS; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; DISEASE PREDISPOSITION; DNA METHYLATION; DNA SEQUENCE; DOSE RESPONSE; EPIGENETICS; EVOLUTIONARY ADAPTATION; FETAL MALNUTRITION; HOMEOSTASIS; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LIFE EVENT; MATERNAL NUTRITION; METABOLIC BALANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; POSTNATAL CARE; PRENATAL EXPOSURE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; TRANSCRIPTION REGULATION;

ANIMALS; ARSENIC; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DISEASE SUSCEPTIBILITY; ENVIRONMENTAL MONITORING; EPIGENESIS, GENETIC; FEMALE; HUMANS; MALNUTRITION; MATERNAL EXPOSURE; MICE; OBESITY; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RISK ASSESSMENT;

EID: 84867267887     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1204934     Document Type: Review

References (137)

1. Adami HO, Lagiou P, Trichopoulos D. 2012. Breast cancer following diethylstilbestrol exposure in utero: insights from a tragedy. Eur J Epidemiol 27:1-3.
2. Almond D. 2006. Is the 1918 Influenza pandemic over? Longterm effects of in utero influenza exposure in the post-1940 U.S. population. J Polit Econ 114:672-712.
3. Anway MD, Leathers C, Skinner MK. 2006. Endocrine disruptor vinclozolin induced epigenetic transgenerational adultonset disease. Endocrinology 147(12):5515-5523.
4. Armitage JA, Khan IY, Taylor PD, Nathanielsz PW, Poston L. 2004. Developmental programming of the metabolic syndrome by maternal nutritional imbalance: how strong is the evidence from experimental models in mammals? J Physiol 561(pt 2):355-377.
5. Atzori L, Antonucci R, Barberini L, Locci E, Marincola FC, Scano P, et al. 2011. 1H NMR-based metabolomic analysis of urine from preterm and term neonates. Front Biosci (Elite Ed) 3:1005-1012.
6. Baharnoori M, Bhardwaj SK, Srivastava LK. 2010. Neonatal behavioral changes in rats with gestational exposure to lipopolysaccharide: a prenatal infection model for developmental neuropsychiatric disorders. Schizophr Bull 38(3):444-456.
7. Banister CE, Koestler DC, Maccani MA, Padbury JF, Houseman EA, Marsit CJ. 2011. Infant growth restriction is associated with distinct patterns of DNA methylation in human placentas. Epigenetics 6(7):920-927.
8. Bartha JL, Comino-Delgado R, Gonzalez-Mena C, Lopez I, Arrabal J. 1998. Umbilical blood flow and neonatal morphometry: a multivariate analysis. Eur J Obstet Gynecol Reprod Biol 79(1):27-33.
9. Baserga M, Hale MA, Wang ZM, Yu X, Callaway CW, McKnight RA, et al. 2007. Uteroplacental insufficiency alters nephrogenesis and downregulates cyclooxygenase-2 expression in a model of IUGR with adult-onset hypertension. Am J Physiol Regul Integr Comp Physiol 292(5):R1943-1955.
10. Bergmann RL, Bergmann KE, Dudenhausen JW. 2008. Undernutrition and growth restriction in pregnancy. Nestle Nutr Workshop Ser Pediatr Program 61:103-121.
11. Brown AS, Patterson PH. 2011. Maternal infection and schizophrenia: implications for prevention. Schizophr Bull 37(2):284-290.
12. Bruin JE, Gerstein HC, Holloway AC. 2010. Long-term consequences of fetal and neonatal nicotine exposure: a critical review. Toxicol Sci 116(2):364-374.
13. Buehler MR. 2011. A proposed mechanism for autism: an aberrant neuroimmune response manifested as a psychiatric disorder. Med Hypotheses 76(6):863-870.
14. Burdge GC, Lillycrop KA. 2010. Nutrition, epigenetics, and developmental plasticity: implications for understanding human disease. Annu Rev Nutr 30:315-339.
15. Carter DE, Aposhian HV, Gandolfi AJ. 2003. The metabolism of inorganic arsenic oxides, gallium arsenide, and arsine: a toxicochemical review. Toxicol Appl Pharmacol 193(3):309-334.
16. Chen CJ, Chiou HY, Chiang MH, Lin LJ, Tai TY. 1996. Doseresponse relationship between ischemic heart disease mortality and long-term arsenic exposure. Arterioscler Thromb Vasc Biol 16(4):504-510.
17. Chen Y, Graziano JH, Parvez F, Liu M, Slavkovich V, Kalra T, et al. 2011. Arsenic exposure from drinking water and mortality from cardiovascular disease in Bangladesh: prospective cohort study. BMJ 342:d2431; doi:10.1136/bmj. d2431 [Online 5 May 2011].
18. Chu T, Handley D, Bunce K, Surti U, Hogge WA, Peters DG. 2011. Structural and regulatory characterization of the placental epigenome at its maternal interface. PLoS One 6(2):e14723; doi:10.1371/journal.pone.0014723 [Online 23 February 2011].
19. Cleasby ME, Kelly PA, Walker BR, Seckl JR. 2003. Programming of rat muscle and fat metabolism by in utero overexposure to glucocorticoids. Endocrinology 144(3):999-1007.
20. da Silva Meirelles L, Chagastelles PC, Nardi NB. 2006. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119(pt 11):2204-2213.
21. Dauphine DC, Ferreccio C, Guntur S, Yuan Y, Hammond SK, Balmes J, et al. 2011. Lung function in adults following in utero and childhood exposure to arsenic in drinking water: preliminary findings. Int Arch Occup Environ Health 84(6):591-600.
22. Davis EF, Newton L, Lewandowski AJ, Lazdam M, Kelly BA, Kyriakou T, et al. 2012. Pre-eclampsia and offspring cardio vascular health: mechanistic insights from experimental studies. Clin Sci (Lond) 123(2):53-72.
23. de Rooij SR, Painter RC, Phillips DI, Osmond C, Michels RP, Bossuyt PM, et al. 2006. Hypothalamic-pituitary-adrenal axis activity in adults who were prenatally exposed to the Dutch famine. Eur J Endocrinol 155(1):153-160.
24. Desai M, Babu J, Ross MG. 2007. Programmed metabolic syndrome: prenatal undernutrition and postweaning overnutrition. Am J Physiol Regul Integr Comp Physiol 293(6):R2306-R2314.
25. Desai M, Gayle D, Babu J, Ross MG. 2005. Programmed obesity in intrauterine growth-restricted newborns: modulation by newborn nutrition. Am J Physiol Regul Integr Comp Physiol 288(1):R91-R96.
26. Dessi A, Atzori L, Noto A, Visser GH, Gazzolo D, Zanardo V, et al. 2011. Metabolomics in newborns with intrauterine growth retardation (IUGR): urine reveals markers of metabolic syndrome. J Matern Fetal Neonatal Med 24(suppl 2):35-39.
27. Dolinoy DC, Huang D, Jirtle RL. 2007. Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development. Proc Natl Acad Sci USA 104(32):13056-13061.
28. Du T, Zamore PD. 2007. Beginning to understand microRNA function. Cell Res 17(8):661-663.
29. Einstein F, Thompson RF, Bhagat TD, Fazzari MJ, Verma A, Barzilai N, et al. 2010. Cytosine methylation dysregulation in neonates following intrauterine growth restriction. PLoS One 5(1):e8887; doi:10.1371/journal.pone.0008887 [Online 26 January 2010].
30. Eriksson JG, Kajantie E, Thornburg KL, Osmond C, Barker DJ. 2011. Mother's body size and placental size predict coronary heart disease in men. Eur Heart J 32(18):2297-2303.
31. Evans RM, Barish GD, Wang YX. 2004. PPARs and the complex journey to obesity. Nat Med 10(4):355-361.
32. Fan Z, Zhang ZX, Li Y, Wang Z, Xu T, Gong X, et al. 2010. Relationship between birth size and coronary heart disease in China. Ann Med 42(8):596-602.
33. Filiberto AC, Maccani MA, Koestler D, Wilhelm-Benartzi C, Avissar-Whiting M, Banister CE, et al. 2011. Birthweight is associated with DNA promoter methylation of the glucocorticoid receptor in human placenta. Epigenetics 6(5):566-572.
34. Fok TF, Hon KL, Ng PC, Wong E, So HK, Lau J, et al. 2009. Use of anthropometric indices to reveal nutritional status: normative data from 10,226 Chinese neonates. Neonatology 95(1):23-32.
35. Fraites MJ, Cooper RL, Buckalew A, Jayaraman S, Mills L, Laws SC. 2009. Characterization of the hypothalamicpituitary-adrenal axis response to atrazine and metabolites in the female rat. Toxicol Sci 112(1):88-99.
36. Fry RC, Navasumrit P, Valiathan C, Svensson JP, Hogan BJ, Luo M, et al. 2007. Activation of inflammation/NF-κB signaling in infants born to arsenic-exposed mothers. PLoS Genet 3(11):e207; doi:10.1371/journal.pgen.0030207 [Online 23 November 2007].
37. Fu Q, McKnight RA, Yu X, Callaway CW, Lane RH. 2006. Growth retardation alters the epigenetic characteristics of hepatic dual specificity phosphatase 5. FASEB J 20(12):2127-2129.
38. Fu Q, Yu X, Callaway CW, Lane RH, McKnight RA. 2009. Epigenetics: intrauterine growth retardation (IUGR) modifies the histone code along the rat hepatic IGF-1 gene. FASEB J 23(8):2438-2449.
39. Godfrey KM, Sheppard A, Gluckman PD, Lillycrop KA, Burdge GC, McLean C, et al. 2011. Epigenetic gene promoter methylat{stroke}ion at birth is associated with child's later adiposity. Diabetes 60(5):1528-1534.
40. Gomes MV, Huber J, Ferriani RA, Amaral Neto AM, Ramos ES. 2009. Abnormal methylation at the KvDMR1 imprinting control region in clinically normal children conceived by assisted reproductive technologies. Mol Hum Reprod 15(8):471-477.
41. Grun F, Blumberg B. 2006. Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling. Endocrinology 147(6 suppl):S50-S55.
42. Grun F, Watanabe H, Zamanian Z, Maeda L, Arima K, Cubacha R, et al. 2006. Endocrine-disrupting organotin compounds are potent inducers of adipogenesis in vertebrates. Mol Endocrinol 20(9):2141-2155.
43. Gustafsson P, Kallen K. 2011. Perinatal, maternal, and fetal characteristics of children diagnosed with attention-deficithyperactivity disorder: results from a population-based study utilizing the Swedish Medical Birth Register. Dev Med Child Neurol 53(3):263-268.
44. Hall M, Gamble M, Slavkovich V, Liu X, Levy D, Cheng Z, et al. 2007. Determinants of arsenic metabolism: blood arsenic metabolites, plasma folate, cobalamin, and homocysteine concentrations in maternal-newborn pairs. Environ Health Perspect 115:1503-1509.
45. Hanson M, Godfrey KM, Lillycrop KA, Burdge GC, Gluckman PD. 2011. Developmental plasticity and developmental origins of non-communicable disease: theoretical considera tions and epigenetic mechanisms. Prog Biophys Mol Biol 106(1):272-280.
46. Heijmans BT, Tobi EW, Stein AD, Putter H, Blauw GJ, Susser ES, et al. 2008. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci USA 105(44):17046-17049.
47. Heinonen K, Raikkonen K, Pesonen AK, Andersson S, Kajantie E, Eriksson JG, et al. 2011. Longitudinal study of smoking cessa tion before pregnancy and children's cognitive abilities at 56 months of age. Early Hum Dev 87(5):353-359.
48. Hemachandra AH, Klebanoff MA, Duggan AK, Hardy JB, Furth SL. 2006. The association between intrauterine growth restriction in the full-term infant and high blood pressure at age 7 years: results from the Collaborative Perinatal Project. Int J Epidemiol 35(4):871-877.
49. Henriksen T, Clausen T. 2002. The fetal origins hypothesis: placental insufficiency and inheritance versus maternal malnutrition in well-nourished populations. Acta Obstet Gynecol Scand 81(2):112-114.
50. Hines EP, White SS, Stanko JP, Gibbs-Flournoy EA, Lau C, Fenton SE. 2009. Phenotypic dichotomy following develop mental exposure to perfluorooctanoic acid (PFOA) in female CD-1 mice: low doses induce elevated serum leptin and insulin, and overweight in mid-life. Mol Cell Endocrinol 304(1-2):97-105.
51. Janesick A, Blumberg B. 2011a. Endocrine disrupting chemicals and the developmental programming of adipogenesis and obesity. Birth Defects Res C Embryo Today 93(1):34-50.
52. Janesick A, Blumberg B. 2011b. Minireview: PPARgamma as the target of obesogens. J Steroid Biochem Mol Biol 127:4-8.
53. Jarvelin MR, Sovio U, King V, Lauren L, Xu B, McCarthy MI, et al. 2004. Early life factors and blood pressure at age 31 years in the 1966 northern Finland birth cohort. Hypertension 44(6):838-846.
54. Johansson S, Iliadou A, Bergvall N, Tuvemo T, Norman M, Cnattingius S. 2005. Risk of high blood pressure among young men increases with the degree of immaturity at birth. Circulation 112(22):3430-3436.
55. Joss-Moore LA, Lane RH. 2009. The developmental origins of adult disease. Curr Opin Pediatr 21(2):230-234.
56. Joss-Moore LA, Metcalfe DB, Albertine KH, McKnight RA, Lane RH. 2010a. Epigenetics and fetal adaptation to perinatal events: diversity through fidelity. J Anim Sci 88(13 suppl):E216-E222.
57. Joss-Moore LA, Wang Y, Campbell MS, Moore B, Yu X, Callaway CW, et al. 2010b. Uteroplacental insufficiency increases visceral adiposity and visceral adipose PPARgamma2 expression in male rat offspring prior to the onset of obesity. Early Hum Dev 86(3):179-185.
58. Kajantie E, Osmond C, Barker DJ, Eriksson JG. 2010. Preterm birth-a risk factor for type 2 diabetes? The Helsinki birth cohort study. Diabetes Care 33(12):2623-2625.
59. Kanayama T, Kobayashi N, Mamiya S, Nakanishi T, Nishikawa J. 2005. Organotin compounds promote adipocyte differentiation as agonists of the peroxisome proliferatoractivated receptor gamma/retinoid X receptor pathway. Mol Pharmacol 67(3):766-774.
60. Katari S, Turan N, Bibikova M, Erinle O, Chalian R, Foster M, et al. 2009. DNA methylation and gene expression differences in children conceived in vitro or in vivo. Hum Mol Genet 18(20):3769-3778.
61. Ke X, Lei Q, James SJ, Kelleher SL, Melnyk S, Jernigan S, et al. 2006. Uteroplacental insufficiency affects epigenetic determinants of chromatin structure in brains of neonatal and juvenile IUGR rats. Physiol Genomics 25(1):16-28.
62. Kirchner S, Kieu T, Chow C, Casey S, Blumberg B. 2010. Prenatal exposure to the environmental obesogen tributyltin pre disposes multipotent stem cells to become adipocytes. Mol Endocrinol 24(3):526-539.
63. Koebnick C, Smith N, Coleman KJ, Getahun D, Reynolds K, Quinn VP, et al. 2010. Prevalence of extreme obesity in a multiethnic cohort of children and adolescents. J Pediatr 157(1):26-31 e22.
64. Lahti J, Raikkonen K, Kajantie E, Heinonen K, Pesonen AK, Jarvenpaa AL, et al. 2006. Small body size at birth and behavioural symptoms of ADHD in children aged five to six years. J Child Psychol Psychiatry 47(11):1167-1174.
65. Lassiter TL, Ryde IT, Mackillop EA, Brown KK, Levin ED, Seidler FJ, et al. 2008. Exposure of neonatal rats to parathion elicits sex-selective reprogramming of metabolism and alters the response to a high-fat diet in adulthood. Environ Health Perspect 116:1456-1462.
66. Leasure JL, Giddabasappa A, Chaney S, Johnson JE Jr, Pothakos K, Lau YS, et al. 2008. Low-level human equiva lent gestational lead exposure produces sex-specific motor and coordination abnormalities and late-onset obesity in year-old mice. Environ Health Perspect 116:355-361.
67. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA. 1995. An antidiabetic thiazoli dinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ). J Biol Chem 270(22):12953-12956.
68. Li JN, Ge YC, Yang Z, Guo CM, Duan T, Myatt L, et al. 2011. The Sp1 transcription factor is crucial for the expression of 11beta-hydroxysteroid dehydrogenase type 2 in human placental trophoblasts. J Clin Endocrinol Metab 96(6):E899-E907.
69. Lillycrop KA, Phillips ES, Torrens C, Hanson MA, Jackson AA, Burdge GC. 2008. Feeding pregnant rats a protein-restricted diet persistently alters the methylation of specific cytosines in the hepatic PPAR alpha promoter of the offspring. Br J Nutr 100(2):278-282.
70. Lillycrop KA, Rodford J, Garratt ES, Slater-Jefferies JL, Godfrey KM, Gluckman PD, et al. 2010. Maternal protein restriction with or without folic acid supplementation during pregnancy alters the hepatic transcriptome in adult male rats. Br J Nutr 103(12):1711-1719.
71. Lillycrop KA, Slater-Jefferies JL, Hanson MA, Godfrey KM, Jackson AA, Burdge GC. 2007. Induction of altered epigenetic regulation of the hepatic glucocorticoid receptor in the offspring of rats fed a protein-restricted diet during pregnancy suggests that reduced DNA methyltransferase-1 expression is involved in impaired DNA methylation and changes in histone modifications. Br J Nutr 97(6):1064-1073.
72. Lithell HO, McKeigue PM, Berglund L, Mohsen R, Lithell UB, Leon DA. 1996. Relation of size at birth to non-insulin dependent diabetes and insulin concentrations in men aged 50-60 years. BMJ 312(7028):406-410.
73. Loaiza S, Coustasse A, Urrutia-Rojas X, Atalah E. 2011. Birth weight and obesity risk at first grade in a cohort of Chilean children. Nutr Hosp 26(1):214-219.
74. Lopez-Jaramillo P, Garcia RG, Lopez M. 2005. Preventing pregnancy-induced hypertension: are there regional differences for this global problem? J Hypertens 23(6):1121-1129.
75. Maccani MA, Avissar-Whiting M, Banister CE, McGonnigal B, Padbury JF, Marsit CJ. 2010. Maternal cigarette smoking during pregnancy is associated with downregulation of miR-16, miR-21, and miR-146a in the placenta. Epigenetics 5(7):583-589.
76. Maccani MA, Marsit CJ. 2009. Epigenetics in the placenta. Am J Reprod Immunol 62(2):78-89.
77. Maccani MA, Padbury JF, Marsit CJ. 2011. miR-16 and miR-21 expression in the placenta is associated with fetal growth. PLoS One 6(6):e21210; e21210. doi:10.1371/journal. pone.0021210 [Online 15 June 2011].
78. Maloney EK, Waxman DJ. 1999. trans-Activation of PPARα and PPARγ by structurally diverse environmental chemicals. Toxicol Appl Pharmacol 161(2):209-218.
79. Martin JA. 2011. Preterm births-United States, 2007. MMWR Surveill Summ 60(suppl):78-79.
80. McCormick DP, Sarpong K, Jordan L, Ray LA, Jain S. 2010. Infant obesity: are we ready to make this diagnosis? J Pediatr 157(1):15-19.
81. Meyer U, Nyffeler M, Yee BK, Knuesel I, Feldon J. 2008. Adult brain and behavioral pathological markers of prenatal immune challenge during early/middle and late fetal development in mice. Brain Behav Immun 22(4):469-486.
82. Meyer U, Weiner I, McAlonan GM, Feldon J. 2011. The neuro pathological contribution of prenatal inflammation to schizophrenia. Expert Rev Neurother 11(1):29-32.
83. Moreno JL, Kurita M, Holloway T, Lopez J, Cadagan R, Martinez-Sobrido L, et al. 2011. Maternal influenza viral infection causes schizophrenia-like alterations of 5-HTA and mGlu receptors in the adult offspring. J Neurosci 31(5):1863-1872.
84. Myatt L. 2010. Review: Reactive oxygen and nitrogen species and functional adaptation of the placenta. Placenta 31(suppl):S66-S69.
85. Myatt L, Roberts VH. 2006. Placental mechanisms and developmental origins of health and disease. In: Developmental Origins of Health and Disease (Gluckman P, Hanson M, eds). Cambridge, UK:Cambridge University Press,130-142.
86. Nelson RE. 2010. Testing the fetal origins hypothesis in a developing country: evidence from the 1918 Influenza Pandemic. Health Econ 19(10):1181-1192.
87. Newbold RR, Padilla-Banks E, Jefferson WN. 2009. Environmental estrogens and obesity. Mol Cell Endocrinol 304(1-2):84-89.
88. Novakovic B, Yuen RK, Gordon L, Penaherrera MS, Sharkey A, Moffett A, et al. 2011. Evidence for widespread changes in promoter methylation profile in human placenta in response to increasing gestational age and environmental/ stochastic factors. BMC Genomics 12:529; doi:10.1186/1471-2164-12-529 [Online 28 October 2011].
89. O'Regan D, Kenyon CJ, Seckl JR, Holmes MC. 2008. Prenatal dexamethasone 'programmes' hypotension, but stressinduced hypertension in adult offspring. J Endocrinol 196(2):343-352.
90. Painter RC, Osmond C, Gluckman P, Hanson M, Phillips DI, Roseboom TJ. 2008. Transgenerational effects of prenatal exposure to the Dutch famine on neonatal adiposity and health in later life. BJOG 115(10):1243-1249.
91. Painter RC, Roseboom TJ, Bleker OP. 2005. Prenatal exposure to the Dutch famine and disease in later life: an overview. Reprod Toxicol 20(3):345-352.
92. Patterson PH. 2011. Maternal infection and immune involvement in autism. Trends Mol Med 17(7):389-394.
93. Patterson RM, Pouliot MR. 1987. Neonatal morphometrics and perinatal outcome: who is growth retarded? Am J Obstet Gynecol 157(3):691-693.
94. Perera F, Tang WY, Herbstman J, Tang D, Levin L, Miller R, et al. 2009. Relation of DNA methylation of 5'-CpG island of ACSL3 to transplacental exposure to airborne polycyclic aromatic hydrocarbons and childhood asthma. PLoS One 4(2):e4488; doi:10.1371/journal.pone.0004488 [Online 16 February 2009].
95. Pham TD, MacLennan NK, Chiu CT, Laksana GS, Hsu JL, Lane RH. 2003. Uteroplacental insufficiency increases apoptosis and alters p53 gene methylation in the full-term IUGR rat kidney. Am J Physiol Regul Integr Comp Physiol 285(5):R962-R970.
96. Pierce BL, Kibriya MG, Tong L, Jasmine F, Argos M, Roy S, et al. 2012. Genome-wide association study identifies chromosome 10q24.32 variants associated with arsenic metabolism and toxicity phenotypes in Bangladesh. PLoS Genet 8(2):e1002522; doi:10.1371/journal.pgen.1002522 [Online 23 February 2012].
97. Pilgaard K, Faerch K, Carstensen B, Poulsen P, Pisinger C, Pedersen O, et al. 2010. Low birthweight and premature birth are both associated with type 2 diabetes in a random sample of middle-aged Danes. Diabetologia 53(12):2526-2530.
98. Pilsner JR, Liu X, Ahsan H, Ilievski V, Slavkovich V, Levy D, et al. 2009. Folate deficiency, hyperhomocysteinemia, low urinary creatinine, and hypomethylation of leukocyte DNA are risk factors for arsenic-induced skin lesions. Environ Health Perspect 117:254-260.
99. Plagemann A, Harder T, Brunn M, Harder A, Roepke K, Wittrock-Staar M, et al. 2009. Hypothalamic proopio melanocortin promoter methylation becomes altered by early overfeeding: an epigenetic model of obesity and the metabolic syndrome. J Physiol 587(pt 20):4963-4976.
100. Ravelli AC, van der Meulen JH, Michels RP, Osmond C, Barker DJ, Hales CN, et al. 1998. Glucose tolerance in adults after prenatal exposure to famine. Lancet 351(9097):173-177.
101. Ravelli GP, Stein ZA, Susser MW. 1976. Obesity in young men after famine exposure in utero and early infancy. N Engl J Med 295(7):349-353.
102. Ren X, McHale CM, Skibola CF, Smith AH, Smith MT, Zhang L. 2011. An emerging role for epigenetic dysregulation in arsenic toxicity and carcinogenesis. Environ Health Perspect 119:11-19.
103. Roseboom T, de Rooij S, Painter R. 2006. The Dutch famine and its long-term consequences for adult health. Early Hum Dev 82(8):485-491.
104. Roseboom TJ, van der Meulen JH, Osmond C, Barker DJ, Ravelli AC, Bleker OP. 2000. Plasma lipid profiles in adults after prenatal exposure to the Dutch famine. Am J Clin Nutr 72(5):1101-1106.
105. Roseboom TJ, van der Meulen JH, Ravelli AC, Osmond C, Barker DJ, Bleker OP. 2001. Effects of prenatal exposure to the Dutch famine on adult disease in later life: an overview. Mol Cell Endocrinol 185(1-2):93-98.
106. Rosen ED, Sarraf P, Troy AE, Bradwin G, Moore K, Milstone DS, et al. 1999. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell 4(4):611-617.
107. Rosenberg HG. 1974. Systemic arterial disease and chronic arsenicism in infants. Arch Pathol 97(6):360-365.
108. Rubin MM. 2007. Antenatal exposure to DES: lessons learned future concerns. Obstet Gynecol Surv 62(8):548-555.
109. Ruthenburg AJ, Li H, Patel DJ, Allis CD. 2007. Multivalent engagement of chromatin modifications by linked binding modules. Nat Rev Mol Cell Biol 8(12):983-994.
110. Sayed D, Abdellatif M. 2011. MicroRNAs in development and disease. Physiol Rev 91(3):827-887.
111. Schug TT, Janesick A, Blumberg B, Heindel JJ. 2011. Endocrine disrupting chemicals and disease susceptibility. J Steroid Biochem Mol Biol 127(3-5):204-215.
112. Seckl JR, Cleasby M, Nyirenda MJ. 2000. Glucocorticoids, 11β -hydroxysteroid dehydrogenase, and fetal programming. Kidney Int 57(4):1412-1417.
113. Seckl JR, Meaney MJ. 2004. Glucocorticoid programming. Ann NY Acad Sci 1032:63-84.
114. Shadid S, Jensen MD. 2003. Effects of pioglitazone versus diet and exercise on metabolic health and fat distribution in upper body obesity. Diabetes Care 26(11):3148-3152.
115. Simmons RA, Templeton LJ, Gertz SJ. 2001. Intrauterine growth retardation leads to the development of type 2 diabetes in the rat. Diabetes 50(10):2279-2286.
116. Simonetti GD, Schwertz R, Klett M, Hoffmann GF, Schaefer F, Wuhl E. 2011. Determinants of blood pressure in preschool children: the role of parental smoking. Circulation 123(3):292-298.
117. Smith AH, Marshall G, Yuan Y, Ferreccio C, Liaw J, von Ehrenstein O, et al. 2006. Increased mortality from lung cancer and bronchiectasis in young adults after exposure to arsenic in utero and in early childhood. Environ Health Perspect 114:1293-1296.
118. Srivastava S, D'Souza SE, Sen U, States JC. 2007. In utero arsenic exposure induces early onset of atherosclerosis in ApoE-/mice. Reprod Toxicol 23(3):449-456.
119. Srivastava S, Vladykovskaya EN, Haberzettl P, Sithu SD, D'Souza SE, States JC. 2009. Arsenic exacerbates athero sclerotic lesion formation and inflammation in ApoE-/-mice. Toxicol Appl Pharmacol 241(1):90-100.
120. States JC, Barchowsky A, Cartwright IL, Reichard JF, Futscher BW, Lantz RC. 2011. Arsenic toxicology: translating between experimental models and human pathology. Environ Health Perspect 119:1356-1363.
121. Steegers-Theunissen RP, Obermann-Borst SA, Kremer D, Lindemans J, Siebel C, Steegers EA, et al. 2009. Periconceptional maternal folic acid use of 400 μg per day is related to increased methylation of the IGF2 gene in the very young child. PLoS One 4(11):e7845; doi:10.1371/journal. pone.0007845 [Online 16 November 2009].
122. Susser E, Neugebauer R, Hoek HW, Brown AS, Lin S, Labovitz D, et al. 1996. Schizophrenia after prenatal famine. Further evidence. Arch Gen Psychiatry 53(1):25-31.
123. Takada I, Kouzmenko AP, Kato S. 2009. Wnt and PPARγ signaling in osteoblastogenesis and adipogenesis. Nat Rev Rheumatol 5(8):442-447.
124. Taveras EM, Rifas-Shiman SL, Belfort MB, Kleinman KP, Oken E, Gillman MW. 2009. Weight status in the first 6 months of life and obesity at 3 years of age. Pediatrics 123(4):1177-1183.
125. Thiering E, Bruske I, Kratzsch J, Thiery J, Sausenthaler S, Meisinger C, et al. 2011. Prenatal and postnatal tobacco smoke exposure and development of insulin resistance in 10 year old children. Int J Hyg Environ Health 214(5):361-368.
126. Tobi EW, Lumey LH, Talens RP, Kremer D, Putter H, Stein AD, et al. 2009. DNA methylation differences after exposure to prenatal famine are common and timingand sex-specific. Hum Mol Genet 18(21):4046-4053.
127. Tokar EJ, Qu W, Waalkes MP. 2011. Arsenic, stem cells, and the developmental basis of adult cancer. Toxicol Sci 120(suppl 1):S192-S203.
128. Tontonoz P, Spiegelman BM. 2008. Fat and beyond: the diverse biology of PPARgamma. Annu Rev Biochem 77:289-312.
129. Torrens C, Poston L, Hanson MA. 2008. Transmission of raised blood pressure and endothelial dysfunction to the F2 generation induced by maternal protein restriction in the F0, in the absence of dietary challenge in the F1 generation. Br J Nutr 100(4):760-766.
130. Tsirka AE, Gruetzmacher EM, Kelley DE, Ritov VH, Devaskar SU, Lane RH. 2001. Myocardial gene expression of glucose transporter 1 and glucose transporter 4 in response to uteroplacental insufficiency in the rat. J Endocrinol 169(2):373-380.
131. Varvarigou AA. 2010. Intrauterine growth restriction as a potential risk factor for disease onset in adulthood. J Pediatr Endocrinol Metab 23(3):215-224.
132. Walther FJ. 1988. Growth and development of term disproportionate small-for-gestational age infants at the age of 7 years. Early Hum Dev 18(1):1-11.
133. Waterland RA. 2006. Assessing the effects of high methionine intake on DNA methylation. J Nutr 136(6 suppl):1706S-1710S.
134. Weaver IC, Cervoni N, Champagne FA, D'Alessio AC, Sharma S, Seckl JR, et al. 2004. Epigenetic programming by maternal behavior. Nat Neurosci 7(8):847-854.
135. vy/a mice. FASEB J 12(11):949-957.
136. Yorifuji T, Tsuda T, Grandjean P. 2010. Unusual cancer excess after neonatal arsenic exposure from contaminated milk powder. J Natl Cancer Inst 102(5):360-361.
137. Yuan Y, Marshall G, Ferreccio C, Steinmaus C, Selvin S, Liaw J, et al. 2007. Acute myocardial infarction mortality in comparison with lung and bladder cancer mortality in arsenicexposed region II of Chile from 1950 to 2000. Am J Epidemiol 166(12):1381-1391.